PB Concentration of NO (μM) ± SEM Fold change, with respect to Control TG TG-F Control 29.59 ± 1.34       TG24 30.61 ± 1.70 (+) 1.03     TG24F 25.01 ± 4.39   (-) 1.22   TG24MF 14.56 ± 2.73   (-) 2.10* (-) 1.72 TG48 31.76 ± 0.47 (+) 1.07     TG48F 40.95 ± 22.18   (+) 1.29   TG48MF 34.10 ± 15.77   (+) 1.07 (-) 1.20 TG72 33.16 ± 2.12 (+) 1.12     TG72F 35.05 ± 9.09   (+) 1.06   TG72MF 47.79 ± 6.04   (+) 1.44 (+) 1.36 TG96 36.26 ± 3.15 (+) 1.23     TG96F 11.29 ± 1.29   (-) 3.21   TG96MF 30.65 ± 8.90   (-) 1.18* (+) 2.71 (#: p<0.05 versus Control; *: p<0.05 versus TG; *: p<0.05 versus TG-F)

Table 5: Concentration and fold changes in nitric oxide produced in peripheral blood, assayed by Griess Reagent, at 540 nm. With fisetin, there is a 1.22 fold decrease after 24 h, and a 3.21 fold decrease after 96 h. With MCN+fisetin, there is a 2.10 fold (p<0.05) decrease after 24h and a 1.18 fold (p<0.05) decrease after 96 h.